Currently available treatments for AD (acetylcholinesterase inhibitors and N-methyl-D-aspartic acid receptor antagonists) have beneficial effects on cognition, function, behaviour, and clinical global changes in patients with AD [38]. The gene discussed is ACHE; the disease is Alzheimer disease.